Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel deep learning-based solution for identification of prognostic subgroups in liver cancer (Hepatocellular carcinoma). | BMC Bioinformatics | 2021 | 34819028 | PubTator, text mining | PubMed |
| Mitotic Errors Promote Genomic Instability and Leukemia in a Novel Mouse Model of Fanconi Anemia. | Front Oncol | 2021 | 34804941 | PubTator, text mining | PubMed |
| Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma. | Med Sci Monit | 2021 | 34799547 | PubTator, text mining | PubMed |
| Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. | PLoS One | 2021 | 34797837 | PubTator, text mining | PubMed |
| Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis. | Front Genet | 2021 | 34795689 | PubTator, text mining | PubMed |
| Studies of Glyoxalase 1-Linked Multidrug Resistance Reveal Glycolysis-Derived Reactive Metabolite, Methylglyoxal, Is a Common Contributor in Cancer Chemotherapy Targeting the Spliceosome. | Front Oncol | 2021 | 34790575 | PubTator, text mining | PubMed |
| Sexually dimorphic patterns in maternal circulating microRNAs in pregnancies complicated by fetal growth restriction. | Biol Sex Differ | 2021 | 34789323 | PubTator, text mining | PubMed |
| MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma. | Genet Test Mol Biomarkers | 2021 | 34788140 | PubTator, text mining | PubMed |
| QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation. | Int J Mol Sci | 2021 | 34768979 | PubTator, text mining | PubMed |
| Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. | MedComm (2020) | 2021 | 34766149 | PubTator, text mining | PubMed |
| Qing Yan Li Ge Tang, a Chinese Herbal Formula, Induces Autophagic Cell Death through the PI3K/Akt/mTOR Pathway in Nasopharyngeal Carcinoma Cells In Vitro. | Evid Based Complement Alternat Med | 2021 | 34765012 | PubTator, text mining | PubMed |
| Loss of sister kinetochore co-orientation and peri-centromeric cohesin protection after meiosis I depends on cleavage of centromeric REC8. | Dev Cell | 2021 | 34758289 | PubTator, text mining | PubMed |
| The p53 family member p73 in the regulation of cell stress response. | Biol Direct | 2021 | 34749806 | PubTator, text mining | PubMed |
| Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma. | Cancer Med | 2021 | 34734491 | PubTator, text mining | PubMed |
| CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20. | Chin Med J (Engl) | 2021 | 34732665 | PubTator, text mining | PubMed |
| [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2021 | 34728029 | PubTator, text mining | PubMed |
| Prognostic evaluation and immune infiltration analysis of five bioinformatic selected genes in hepatocellular carcinoma. | J Cell Mol Med | 2021 | 34726341 | PubTator, text mining | PubMed |
| SARS-CoV-2-host proteome interactions for antiviral drug discovery. | Mol Syst Biol | 2021 | 34709727 | PubTator, text mining | PubMed |
| Phosphorylation and Pin1 binding to the LIC1 subunit selectively regulate mitotic dynein functions. | J Cell Biol | 2021 | 34709360 | PubTator, text mining | PubMed |
| Expression of spindle assembly checkpoint proteins BubR1 and Mad2 expression as potential biomarkers of malignant transformation of oral leukoplakia: an observational cohort study. | Med Oral Patol Oral Cir Bucal | 2021 | 34704983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=35